BMY
53
-7
MTCH
37
7
APA
21
2
ROK
55
8
ICE
59
-3
JNPR
46
3
EIX
77
2
HUM
48
6
EOG
58
2
UNH
61
6
PSA
51
-4
CAH
47
3
FRT
39
-2
BA
52
2
DHI
48
3
MPC
47
3
FDX
36
-4
PNW
66
3
RRC
63
3
LUV
39
-5
BMY
53
-7
MTCH
37
7
APA
21
2
ROK
55
8
ICE
59
-3
JNPR
46
3
EIX
77
2
HUM
48
6
EOG
58
2
UNH
61
6
PSA
51
-4
CAH
47
3
FRT
39
-2
BA
52
2
DHI
48
3
MPC
47
3
FDX
36
-4
PNW
66
3
RRC
63
3
LUV
39
-5
Financhill
Back

Alkermes PLC 10K Form

Sell
48

ALKS
Alkermes PLC

Last Price:
27.70
Seasonality Move:
23.4%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-01 10Q ALKS/Alkermes PLC Quarterly
2023-10-25 10Q ALKS/Alkermes PLC Quarterly
2023-07-26 10Q ALKS/Alkermes PLC Quarterly
2023-04-26 10Q ALKS/Alkermes PLC Quarterly
2022-11-02 10Q ALKS/Alkermes PLC Quarterly
2022-07-27 10Q ALKS/Alkermes PLC Quarterly

Receive ALKS News And Ratings

See the #1 stock for the next 7 days that we like better than ALKS

ALKS Financial Statistics

Sales & Book Value

Annual Sales: $1.66B
Cash Flow: $73.33M
Price / Cash Flow: 14.81
Annual Sales: $7.99
Price / Book: 3.45

Profitability

EPS (TTM): 1.95000
Net Income (TTM): $333.35M
Gross Margin: $1.41B
Return on Equity: 26.09%
Return on Assets: 15.29%

Alkermes PLC Earnings Forecast

Key Alkermes PLC Financial Ratios

  • The Gross Profit Margin over the past 32 years for ALKS is 84.79%.
  • The Selling, General & Administrative Expenses for ALKS have been equal to 41.47% of Gross Profit Margin.
  • The Research & Development expenses have been 16.28% of Revenue.
  • The Interest Expense is 6.47% of Operating Income.
  • The Net Earning history of ALKS is 21.39% of Total Revenues.
  • Per Share Earnings over the last 32 years have been positive in 16 years.

Alkermes PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ALKS
CUSIP: G01767
Website: alkermes.com

Debt

Debt-to-Equity Ratio: 0.22
Current Ratio: 3.45
Quick Ratio: 2.82

Price-to-Earnings

Trailing P/E Ratio: 13.12
Forward P/E Ratio: 15.56

ALKS Technical Analysis vs Fundamental Analysis

Sell
48
Alkermes PLC (ALKS) is a Sell

Is Alkermes PLC a Buy or a Sell?

  • Alkermes PLC stock is rated a Sell
    The current Alkermes PLC [ALKS] share price is $27.91. The Score for ALKS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.